| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2011-06-13 | NY-ESO-1c259-T cell therapy product | metastatic melanoma | 1-2 | Adaptimmune (UK) | Cancer - Oncology |
| 2011-06-10 | lung cancer vaccine CV9201 | patients with metastatic non small-cell lung carcinoma who had previously undergone chemotherapy | 1-2a | Curevac (Germany) | Cancer - Oncology |
| 2011-06-09 | cilengitide | glioblastoma |
3 | Merck Serono, a Merck KGaA company (Germany) | Cancer - Oncology |
| 2011-06-08 | PM01183 (lurbinectidin) | metastatic pancreatic cancer | 1 | PharmaMar (Spain) | Cancer - Oncology |
| 2011-06-08 | vidofludimus | rheumatoid arthritis |
2b | 4SC (Germany) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2011-06-08 | V710 | prevention of Staphylococcus aureus (S. aureus) infection | 2-3 | Merck&Co (USA) Intercell (Austria) | Infectious diseases |
| 2011-06-06 | SYL1001 (tivanisiran) | eye discomfort | 1 | Sylentis (Spain) | Ophtalmological diseases |
| 2011-06-06 | Removab®(catumaxomab) | malignant ascites gastric cancer |
Trion Pharma (Germany) Fresenius Biotech (Germany) | Cancer - Oncology | |
| 2011-06-06 | Irosustat | endometrial cancer | 2 | Ipsen (France) | Cancer - Oncology |
| 2011-06-06 | Zaltrap® (aflibercept) | metastatic colorectal cancer |
3 | Sanofi (France) Regeneron Pharmaceuticals (USA) | Cancer - Oncology |
| 2011-06-06 | lipegfilgrastim | prevention of chemotherapy-induced neutropenia in breast cancer patients | 3 | Teva Pharmaceutical Industries (Israel) | Cancer - Oncology |
| 2011-06-05 | talactoferrin | severe sepsis | 2 | Agennix (Germany) | Infectious diseases |
| 2011-06-05 | vemurafenib | metastatic melanoma | 3 | Roche (Switzerland) | Cancer - Oncology |
| 2011-06-04 | inecalcitol | psoriasis | 2 | Hybrigenics (France) | Autoimmune diseases - Dermatological diseases |
| 2011-06-04 | Avastin® (bevacizumab) in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of Avastin® alone | recurrent platinum-sensitive ovarian cancer | 3 | Roche (Switzerland) | Cancer - Oncology |
| 2011-06-04 | INC424 (ruxolitinib) | myelofibrosis | 3 | Novartis (Switzerland | Blood diseases - Cancer - Oncology |
| 2011-06-04 | semuloparin | venous thrombo-embolism (VTE) in cancer patients | 3 | Sanofi (France) | Cancer - Oncology - Cardiovascular diseases |
| 2011-06-03 | NGR-hTNF | non-small cell lung cancer | 2 | MolMed (Italy) | Cancer - Oncology |
| 2011-06-03 | NGR-hTNF | relapsed small-cell lung cancer | 2 | MolMed (Italy) | Cancer - Oncology |
| 2011-06-03 | NGR-hTNF | 2 | MolMed (Italy) | Cancer - Oncology |
